Global Epigenetics Market - Segmented by Kits, Reagents, Enzymes, Instruments, Application, Technology, and Geography - Growth, Trends, and Forecast (2018 - 2023)
The global epigenetics market is estimated to grow rapidly at a CAGR of over 20% during the forecast period. Epigenetics is defined as the study of changes in gene expression, which are caused by certain base pairs in DNA, or RNA, being turned off or on again, through the chemical reactions.
Increasing Incidence and Prevalence of Cancer
According to Cancer Research UK, in 2012, 14.1 million new cases of cancer were diagnosed worldwide. The World Health Organization estimated that this figure may rise to 35 million new cases in 2035. It is also estimated that nearly 550,000 new cases are diagnosed with head and neck cancer each year, across the world. It is estimated that nearly 6% of the malignancies occur in the United States. According to the American Cancer society, nearly 40,000 people in the United States are diagnosed with head and neck cancer, of which 12,000 were supposed to die in the year 2014 alone. This depicts the large patient pool of cancer patients, which will propel the growth of the epigenetics market. The other factors, like increasing funding for R&D in healthcare and the rising epigenetic applications in non-oncology diseases, are driving the market.
Rising Cost of Instruments
The epigenetic instruments cost is rising gradually, and this increase is becoming one of the major restrains for the growth of the market. The instruments, such as mass spectrometers, sonicators, and the next generation sequences, are already costly, and the rising cost of these instruments are going to increase the cost for the genetic test, which simultaneously decreases the adoption rate of epigenetics. And the lack of skilled researchers is restraining the market growth of epigenetics.
The United States has the Highest Market Share
In North America, the United States is dominating the epigenetics market due to the factors, such as increasing prevalence rate of cancer, increasing funding for the R&D, and the increasing collaborations between several large pharmaceutical companies for development of enhanced therapeutics. Asia-Pacific is expected to record a substantial growth over the forecast period.
Key Developments in the Market
December 2017: Roche and Ignyta made definitive merger agreement
December 2017: Zymo Research collaborated with Bertin
Major Players: ABCAM PLC, ACTIVE MOTIFF, DIAGENODE INC, ILLUMINA INC, MERCK & CO., QIAGEN, SIGMA ALDRICH CORPORATION, THERMO FISHER SCIENTIFIC, ZYMO RESEARCH CORPORATION, and ROCHE, amongst others
Reasons to Purchase the Report
Current and future market outlook for epigenetics in the developed and emerging markets
Analyze various perspectives on the market, with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth, during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3-month analyst support, along with the market estimate sheet (in excel)
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.